Imaging systems have been utilized in non-clinical and clinical trials to detect diseases since ages. Clinical imaging is now mostly used to obtain undeniable and interpretable human physiology or anatomy information. The clinical inferences drawn from an image are crucial in evaluation of the drug effect. Clinical trial imaging data collection, interpretation, and submission are all improving because to technological advancements. Over the last two decades, the use of imaging in clinical trials has increased significantly. In several trials, imaging data is increasingly being used to support the primary endpoint.
The "Global Clinical Trial Imaging Market Analysis to 2028" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the clinical trial imaging market with detailed market segmentation by modality, products and services, end user, and geography. The report provides key statistics on the market status of the leading clinical trial imaging market players and offers key trends and opportunities in the market.
- Based on modality, the global clinical trial imaging market is segmented into magnetic resonance imaging, computed tomography, ultrasound, positron emission tomography, X-ray, echocardiography, and others.
- On the basis of products and services, the market is segmented into services and software.
- Based on end user, the market is bifurcated into pharmaceutical companies, contract research organizations, academic and government research, biotechnology companies, and others.
- Rising Number of Contract Research Organization.
- Growing in Geriatric Population with Chronic Diseases.
- Growth in R&D Investments.
- Growth in the Pharmaceutical and Biotechnological Companies.s
- High Implementation Cost of Imaging Systems.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The clinical trial imaging market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the clinical trial imaging market in these regions.
IMPACT OF COVID-19 ON CLINICAL TRIAL IMAGING MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities. Because imaging can provide highly relevant data for clinical research, it's no wonder that regulators are seeking it increasingly frequently. Thus, COVID-19 is likely to have positive impact on clinical trial imaging market.
The report covers key developments in the clinical trial imaging market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from clinical trial imaging market are anticipated to lucrative growth opportunities in the future with the rising demand for clinical trial imaging in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the clinical trial imaging market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Parexel International Corporation.
- ICON plc
- IXICO plc
- Intrinsic Imaging, LLC
- ERT Clinical
- BioTelemetry, Inc.
- Cardiovascular Imaging Technologies
- Medical Metrics
- Prism Clinical Imaging
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.